Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023

-
Image
pediatrics associates of dallas :: Article Creator Pediatric Diagnostic Associates Will Continue Serving Families As A Practice Independent Of CHI Memorial Pediatric Diagnostic Associates, which was previously associated with CHI Memorial Hospital, announced Thursday it will again become an independent practice under newly formed Scenic City Pediatrics PLLC. Effective Feb. 1, the medical group will enter a new contract with BlueCross BlueShield of Tennessee, including Networks P and S, among other insurers, according to a news release. The change follows a June decision on BlueCross BlueShield of Tennessee's behalf to terminate its contract with Memorial relating to its Network S customers. Managing Partner Dr. Tony Friddell said in a phone interview Pediatric Diagnostic Associates has been under the CHI Memorial umbrella as a managed practice within the hospital system for 28 years. In some shape or form, Pediatric Diagnostic Associates...
Post a Comment

Asia-Pacific DNA Vaccines Market 2019-2027 - Surge in New Vaccine Development Drives the Market - PRNewswire

-

DUBLIN, Dec. 30, 2019 /PRNewswire/ -- The "Asia-Pacific DNA Vaccines Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

The Asia-Pacific DNA vaccines market is expected to make progressive growth at a CAGR of 42.79% in terms of revenue throughout the estimated period of 2019-2027.

The important players include Astellas Pharma, Inc., Dendreon Corporation (acquired by Sanpower Group), Eli Lilly and Company, Eurogentec S.A., GlaxoSmithKline, Inc., Inovio Pharmaceuticals, Inc. and Madison Vaccines, Incorporated (MVI).

Japan, India, China, South Korea, Australia & New Zealand, ASEAN countries and countries in rest of APAC together constitute the market for DNA vaccines in the Asia-Pacific region.

The DNA vaccines market in China is mainly driven by the growing investments by the government of China for clinical trials and development of DNA vaccines towards the treatment of chronic diseases such as cancer, HPV, diabetes, etc.

In March 2015, China's Ministry of Science and Technology introduced a nationwide precision medicine-driven health program with an approximate investment of $9.2 billion over the forthcoming 15 years, starting in 2016 and ending by 2030.

The near-term objective was to bring the precision medicine concept into normal prevention procedure that included DNA-based vaccination for chronic disease prevention, such as cerebrovascular, cardiovascular and metabolic diseases, cancer, etc.

The final objective of this health investment program was aimed at enhancing the prevention capabilities of diseases, while simultaneously developing improved therapeutics depending upon the latest DNA-based translational research. These were directed towards achieving enhanced results in the country's public health management program.

There is an ongoing research for the development of DNA vaccines for the successful prevention of mucopolysaccharidosis, maxillomandibular advancement, narcissistic personality disorder, etc. in Shanghai and Beijing.

Key Topics Covered

1. Asia-Pacific DNA Vaccines Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threats of Substitute Product
2.2.3. Bargaining Power of Buyer
2.2.4. Bargaining Power of Supplier
2.2.5. Intensity of Competitive Rivalry
2.3. Vendor Scorecard
2.4. Value Chain Outlook
2.5. Key Insights
2.6. Regulatory Framework
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Surge in New Vaccine Development
2.8.2. Rise in the Usage of DNA Vaccines for Animal Healthcare
2.8.3. Rising Prevalence of Chronic and Infectious Diseases
2.9. Market Restraints
2.9.1. Lack of Legal and Ethical Framework
2.9.2. Stringent Government Regulations
2.10. Market Opportunities
2.10.1. Growing Demand for Gene Therapy
2.10.2. Steady Vaccines Are Easy to Store and Transport
2.10.3. Increasing Number of Clinical Trials on Humans
2.11. Market Challenges
2.11.1. Variation in the Regulatory Pathway and the Points of Consideration Regarding Environmental Valuation

3. DNA Vaccines Market Outlook - by Type
3.1. Animal DNA Vaccine
3.2. Human DNA Vaccine

4. DNA Vaccines Market Outlook - by Application
4.1. Human Disease
4.2. Veterinary Disease

5. DNA Vaccines Market Outlook - by Technology
5.1. Plasmid DNA Vaccines
5.2. Plasmid DNA Delivery

6. DNA Vaccines Market Outlook - by Region
6.1. Asia-Pacific
6.1.1. Country Analysis
6.1.1.1. India
6.1.1.2. China
6.1.1.3. Japan
6.1.1.4. Australia & New Zealand
6.1.1.5. South Korea
6.1.1.6. Asean Countries
6.1.1.7. Rest of Asia-Pacific

7. Competitive Landscape
7.1. Astellas Pharma, Inc.
7.2. Dendreon Corporation (Acquired by Sanpower Group)
7.3. Eli Lilly and Company
7.4. Eurogentec S.A.
7.5. Glaxosmithkline, Inc.
7.6. Inovio Pharmaceuticals, Inc.
7.7. Madison Vaccines, Incorporated (Mvi)
7.8. Merck & Co.
7.9. Merial Limited (Acquired by Boehringer Ingelheim)
7.10. Novartis AG
7.11. Sanofi
7.12. Vgxi
7.13. Vical, Incorporated
7.14. Xenetic Biosciences, Inc.
7.15. Zoetis, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/1sxy95

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com



Comments

Post a Comment

Popular posts from this blog

These Are the Top Doctors in the Hudson Valley in 2022

-
Image
advanced primary care of the ozarks :: Article Creator Integrating Rx With Advanced Primary Care Will Unlock Better Health America's healthcare industry has been squeezed tightly over the past few years with post-pandemic fallout, a declining economy and high consumer expectations. Retail pharmacies are no exception, and it's clear that the traditional pharmacy model is in crisis. With rising costs for medications and supplies and changing consumer retail habits, this doesn't bode well for the brick-and-mortar community pharmacy. Simply put: the traditional pharmacy model is unsustainable. We will soon see a rash of closing retail pharmacies and consumers scrambling to fill needed prescriptions affordably. You might be asking yourself why this should matter to you as HR and benefit professionals. I serve as chief human resources officer for a company that works with many large employers concerned about healthcare costs and the de...
Read more

William Buoni, MD - Wexner Medical Center

-
Image
podiatry billing company :: Article Creator The Best Medical Billing Services Of 2024 1. Get a full picture of the company's features. Claim scrubbing and follow-up are par for the course. You'll also commonly find that RCM companies include reporting, consultation, and EMR and PMS access with your services. Check for these features as you speak with company representatives. You should also determine whether the features that accompany your medical billing leave the company or your own team responsible for entering and coding charges. It's worth asking if your billing service candidates are following the most recent ICD-10 coding system updates. You should also get a sense of the billing company's experience with other practices in your specialty. Lastly, ask about the depth and extent of reporting and analytics solutions. "You'll want to ensure that your medical billing service has implemented & maintains timely bill...
Read more

Who are the top doctors in Columbus? Search by specialty with Columbus Monthly's 2021 list

-
Image
women's preventive services :: Article Creator Women - Search News Team USA wins women's 4x400 for eighth consecutive Olympic gold medal The U.S. Women's have dominated the 4x400 relay, winning eight golds in a row in the event. When Team USA won it in Tokyo it gave the legendary Allyson Felix her 11th Olympic medal, making her the most decorated track and field athlete of all time.
Read more